Scarica l'app Stockscreener
6.89
0.29%
-0.02
Pre-mercato:
6.88
-0.010
-0.15%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ACCD Giù?
Forum
Previsione
Precedente Chiudi:
$6.91
Aprire:
$6.9
Volume 24 ore:
605.13K
Relative Volume:
0.31
Capitalizzazione di mercato:
$562.77M
Reddito:
$414.29M
Utile/perdita netta:
$-99.81M
Rapporto P/E:
-5.1618
EPS:
-1.3348
Flusso di cassa netto:
$-28.65M
1 W Prestazione:
-0.14%
1M Prestazione:
+0.00%
6M Prestazione:
+61.36%
1 anno Prestazione:
-44.26%
Intervallo 1D:
$6.89
$6.91
Intervallo di 1 settimana:
$6.88
$6.91
Portata 52W:
$3.08
$12.24
Accolade Inc Stock (ACCD) Company Profile
Nome
Accolade Inc
Settore
Industria
Telefono
610-834-2989
Indirizzo
660 W. GERMANTOWN PIKE SUITE 500, PLYMOUTH MEETING
Confronta ACCD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACCD
Accolade Inc
|
6.89 | 562.77M | 414.29M | -99.81M | -28.65M | -1.3348 |
|
VEEV
Veeva Systems Inc
|
229.19 | 37.21B | 2.66B | 665.91M | 1.08B | 4.05 |
|
DOCS
Doximity Inc
|
76.68 | 14.39B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
85.71 | 13.49B | 640.44M | -743.28M | -206.93M | -11.29 |
|
SOLV
Solventum Corp
|
73.98 | 12.78B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
HQY
Healthequity Inc
|
113.78 | 9.86B | 1.15B | 96.70M | -161.99M | 1.09 |
Accolade Inc Stock (ACCD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-28 | Reiterato | Needham | Buy |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-01-17 | Ripresa | DA Davidson | Neutral |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2023-05-24 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-04-12 | Iniziato | Stephens | Overweight |
| 2023-03-23 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2023-02-09 | Downgrade | Jefferies | Buy → Hold |
| 2023-02-02 | Iniziato | Raymond James | Outperform |
| 2022-09-08 | Ripresa | Piper Sandler | Overweight |
| 2022-09-07 | Iniziato | Truist | Buy |
| 2022-08-12 | Iniziato | DA Davidson | Buy |
| 2022-05-02 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-04-29 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-04-29 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-04-29 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-04-29 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-29 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-11 | Iniziato | Wells Fargo | Underweight |
| 2022-04-07 | Iniziato | Guggenheim | Neutral |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-02-11 | Iniziato | Goldman | Buy |
| 2021-12-02 | Iniziato | Jefferies | Buy |
| 2021-09-30 | Iniziato | Berenberg | Buy |
| 2021-09-17 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2021-05-28 | Iniziato | Robert W. Baird | Neutral |
| 2021-05-06 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2021-04-15 | Iniziato | Needham | Buy |
| 2021-03-11 | Ripresa | Goldman | Buy |
| 2021-01-15 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2021-01-07 | Iniziato | BTIG Research | Buy |
| 2020-12-08 | Iniziato | Canaccord Genuity | Buy |
| 2020-09-22 | Iniziato | DA Davidson | Buy |
| 2020-07-27 | Iniziato | BofA Securities | Buy |
| 2020-07-27 | Iniziato | Credit Suisse | Neutral |
| 2020-07-27 | Iniziato | Goldman | Buy |
| 2020-07-27 | Iniziato | Morgan Stanley | Overweight |
| 2020-07-27 | Iniziato | Piper Sandler | Overweight |
| 2020-07-27 | Iniziato | Robert W. Baird | Outperform |
| 2020-07-27 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Accolade Inc Borsa (ACCD) Ultime notizie
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Accolade, Inc. (NasdaqACCD), Paragon 28, Inc. (NYSEFNA), Logility Supply Chain Solutions, Inc. (NasdaqLGTY), Enfusion, Inc. (NYSEENFN) - Morningstar
Accolade CFO Barnes sells shares worth $1,521 - MSN
Acclade CEO Rajeev Singh sells shares worth $8,103 - MSN
AcColade CFO Barnes sells shares worth $1,056 - MSN
Fairman Group LLC Has $6.16 Million Stake in Accolade, Inc. (NASDAQ:ACCD) - MarketBeat
Accolade, Inc. (NASDAQ:ACCD) Sees Significant Decline in Short Interest - MarketBeat
Accolade president Robert Cavanaugh sells $1,735 in stock - MSN
Sumitomo Mitsui Trust Group Inc. Decreases Holdings in Accolade, Inc. (NASDAQ:ACCD) - MarketBeat
Accolade (NASDAQ:ACCD) Given "Equal Weight" Rating at Stephens - MarketBeat
Accolade president Robert Cavanaugh sells $1,735 in stock By Investing.com - Investing.com South Africa
Accolade CEO Rajeev Singh sells $3,504 in stock - MSN
Accolade CFO Barnes sells shares worth $1,521 By Investing.com - Investing.com Nigeria
$TOCKHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – ENFN, VCSA, ACCD, AVAV - GlobeNewswire Inc.
Accolade CEO Rajeev Singh sells $3,504 in stock By Investing.com - Investing.com Australia
Brokerages Set Accolade, Inc. (NASDAQ:ACCD) PT at $7.55 - MarketBeat
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The MergerKAVL, VCSA, ACCD, AVAV - The Malaysian Reserve
Accolade president Robert Cavanaugh sells shares worth $3,857 By Investing.com - Investing.com Australia
Accolade president Robert Cavanaugh sells shares worth $3,857 - MSN
Accolade's EVP Richard Eskew sells $2,701 in stock - Investing.com India
Accolade's EVP Richard Eskew sells $2,701 in stock By Investing.com - Investing.com South Africa
Accolade Expands Virtual Care to Medicare Beneficiaries Nationwide Through PlushCare Direct-to-Consumer Offering - PR Newswire
Accolade, Inc. (NASDAQ:ACCD) Short Interest Up 10.3% in January - MarketBeat
Accolade Sports Collection Review: A Retro Trip with Clunky Gameplay - imdb
Nisa Investment Advisors LLC Raises Holdings in Accolade, Inc. (NASDAQ:ACCD) - MarketBeat
Why Accolade Inc (ACCD) Is Skyrocketing So Far In 2025 - Insider Monkey
Cathie Wood's ARK ETF Buys CRISPR, Sells Roblox and Accolade Stock - MSN
Financial Analysis: Smart Powerr (NASDAQ:CREG) and Accolade (NASDAQ:ACCD) - Defense World
Cathie Wood's ARK ETF Buys CRISPR, Sells Roblox and Accolade Stock By Investing.com - Investing.com South Africa
Accolade, Inc. (NASDAQ:ACCD) Short Interest Update - Defense World
Cathie Wood's Ark Invest Bets On Biotech With CRISPR Therapeutics Investment, Exits Roblox - Benzinga
Cathie Wood’s ARK ETF Buys CRISPR, Sells Roblox and Accolade Stock - Investing.com Nigeria
Halper Sadeh LLC Investigates Accolade, Inc. Sale to Transcarent for Fairness to Shareholders - HPBL
Nisa Investment Advisors LLC Buys 55,314 Shares of Accolade, Inc. (NASDAQ:ACCD) - Defense World
Investigation into Accolade Transaction with Transcarent: Potential Breach of Fiduciary Duty – Market - HPBL
Accolade Inc. (ACCD): Q3 2025 Earnings Preview and Stock Outlook – Market - HPBL
Geode Capital Management Increases Stake in Accolade, Inc. – Market - HPBL
Accolade Sports Collection takes a swing at Switch today - GoNintendo
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Accolade, Inc.ACCD - Victoria Advocate
Accolade (ACCD) Stock Update: Analyst Ratings and Market Performance – Market - HPBL
Accolade Inc Azioni (ACCD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.00%
5.64%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):